These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32690641)

  • 21. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis.
    Tamraz B; Fukushima H; Wolfe AR; Kaspera R; Totah RA; Floyd JS; Ma B; Chu C; Marciante KD; Heckbert SR; Psaty BM; Kroetz DL; Kwok PY
    Pharmacogenet Genomics; 2013 Jul; 23(7):355-64. PubMed ID: 23652407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of HEK293 cells stably expressing wild-type organic anion transporting polypeptide 1B1 (OATP1B1*1a) and variant OATP1B1*1b and OATP1B1*15.
    Chen M; Qu BX; Chen XL; Hu HH; Jiang HD; Yu LS; Zhou Q; Zeng S
    Pharmazie; 2016 Jun; 71(6):337-9. PubMed ID: 27455553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
    Zhang W; He YJ; Gan Z; Fan L; Li Q; Wang A; Liu ZQ; Deng S; Huang YF; Xu LY; Zhou HH
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1240-4. PubMed ID: 17973861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.
    Yamaguchi H; Takeuchi T; Okada M; Kobayashi M; Unno M; Abe T; Goto J; Hishinuma T; Shimada M; Mano N
    Biol Pharm Bull; 2011; 34(3):389-95. PubMed ID: 21372390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
    de Graan AJ; Lancaster CS; Obaidat A; Hagenbuch B; Elens L; Friberg LE; de Bruijn P; Hu S; Gibson AA; Bruun GH; Corydon TJ; Mikkelsen TS; Walker AL; Du G; Loos WJ; van Schaik RH; Baker SD; Mathijssen RH; Sparreboom A
    Clin Cancer Res; 2012 Aug; 18(16):4433-40. PubMed ID: 22711709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
    Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
    Zimmerman EI; Hu S; Roberts JL; Gibson AA; Orwick SJ; Li L; Sparreboom A; Baker SD
    Clin Cancer Res; 2013 Mar; 19(6):1458-66. PubMed ID: 23340295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.
    Hartkoorn RC; Kwan WS; Shallcross V; Chaikan A; Liptrott N; Egan D; Sora ES; James CE; Gibbons S; Bray PG; Back DJ; Khoo SH; Owen A
    Pharmacogenet Genomics; 2010 Feb; 20(2):112-20. PubMed ID: 20051929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers.
    Furihata T; Satoh T; Yamamoto N; Kobayashi K; Chiba K
    Pharm Res; 2007 Dec; 24(12):2327-32. PubMed ID: 17932728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells.
    Kameyama Y; Yamashita K; Kobayashi K; Hosokawa M; Chiba K
    Pharmacogenet Genomics; 2005 Jul; 15(7):513-22. PubMed ID: 15970799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions.
    Shitara Y
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):220-7. PubMed ID: 21297316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental and Modeling Evidence Supporting the
    Izumi S; Nozaki Y; Lee W; Sugiyama Y
    Drug Metab Dispos; 2022 May; 50(5):541-551. PubMed ID: 35241487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
    Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
    Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
    Smith NF; Figg WD; Sparreboom A
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
    Bednarczyk D; Boiselle C
    Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin.
    Varma MV; Lin J; Bi YA; Rotter CJ; Fahmi OA; Lam JL; El-Kattan AF; Goosen TC; Lai Y
    Drug Metab Dispos; 2013 May; 41(5):966-74. PubMed ID: 23393219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide.
    Jiang R; Hart A; Burgess L; Kim DS; Lai WG; Dixit V
    Drug Metab Dispos; 2021 Mar; 49(3):265-275. PubMed ID: 33355210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers.
    Takehara I; Terashima H; Nakayama T; Yoshikado T; Yoshida M; Furihata K; Watanabe N; Maeda K; Ando O; Sugiyama Y; Kusuhara H
    Pharm Res; 2017 Aug; 34(8):1601-1614. PubMed ID: 28550384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.